These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 26234533)

  • 1. Comparing α7 nicotinic acetylcholine receptor binding, amyloid-β deposition, and mitochondria complex-I function in living brain: A PET study in aged monkeys.
    Nishiyama S; Ohba H; Kanazawa M; Kakiuchi T; Tsukada H
    Synapse; 2015 Oct; 69(10):475-83. PubMed ID: 26234533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo Depiction of α7 Nicotinic Receptor Loss for Cognitive Decline in Alzheimer's Disease.
    Nakaizumi K; Ouchi Y; Terada T; Yoshikawa E; Kakimoto A; Isobe T; Bunai T; Yokokura M; Suzuki K; Magata Y
    J Alzheimers Dis; 2018; 61(4):1355-1365. PubMed ID: 29376856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and evaluation of new imaging agent for central nicotinic acetylcholine receptor α7 subtype.
    Ogawa M; Nishiyama S; Tsukada H; Hatano K; Fuchigami T; Yamaguchi H; Matsushima Y; Ito K; Magata Y
    Nucl Med Biol; 2010 Apr; 37(3):347-55. PubMed ID: 20346874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparing amyloid-β deposition, neuroinflammation, glucose metabolism, and mitochondrial complex I activity in brain: a PET study in aged monkeys.
    Tsukada H; Nishiyama S; Ohba H; Kanazawa M; Kakiuchi T; Harada N
    Eur J Nucl Med Mol Imaging; 2014 Nov; 41(11):2127-36. PubMed ID: 24919653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of 18F-BCPP-EF for mitochondrial complex 1 imaging in the brain of conscious monkeys using PET.
    Tsukada H; Ohba H; Kanazawa M; Kakiuchi T; Harada N
    Eur J Nucl Med Mol Imaging; 2014 Apr; 41(4):755-63. PubMed ID: 24258008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of MPTP on Serotonergic Neuronal Systems and Mitochondrial Complex I Activity in the Living Brain: A PET Study on Conscious Rhesus Monkeys.
    Kanazawa M; Ohba H; Nishiyama S; Kakiuchi T; Tsukada H
    J Nucl Med; 2017 Jul; 58(7):1111-1116. PubMed ID: 28280215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitochondrial complex I abnormalities is associated with tau and clinical symptoms in mild Alzheimer's disease.
    Terada T; Therriault J; Kang MSP; Savard M; Pascoal TA; Lussier F; Tissot C; Wang YT; Benedet A; Matsudaira T; Bunai T; Obi T; Tsukada H; Ouchi Y; Rosa-Neto P
    Mol Neurodegener; 2021 Apr; 16(1):28. PubMed ID: 33902654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of α7 nicotinic acetylcholine receptor and fibrillar amyloid-β interactions in Alzheimer's disease brain.
    Ni R; Marutle A; Nordberg A
    J Alzheimers Dis; 2013; 33(3):841-51. PubMed ID: 23042213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel PET probes 18F-BCPP-EF and 18F-BCPP-BF for mitochondrial complex I: a PET study in comparison with 18F-BMS-747158-02 in rat brain.
    Tsukada H; Nishiyama S; Fukumoto D; Kanazawa M; Harada N
    J Nucl Med; 2014 Mar; 55(3):473-80. PubMed ID: 24470629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of ¹⁸F-BCPP-EF as a PET probe for complex I activity in the brain.
    Tsukada H
    Methods Enzymol; 2014; 547():417-31. PubMed ID: 25416368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PET imaging evaluation of [(18)F]DBT-10, a novel radioligand specific to α7 nicotinic acetylcholine receptors, in nonhuman primates.
    Hillmer AT; Zheng MQ; Li S; Scheunemann M; Lin SF; Holden D; Labaree D; Ropchan J; Teodoro R; Deuther-Conrad W; Carson RE; Brust P; Huang Y
    Eur J Nucl Med Mol Imaging; 2016 Mar; 43(3):537-47. PubMed ID: 26455500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The distribution of the alpha7 nicotinic acetylcholine receptor in healthy aging: An in vivo positron emission tomography study with [
    Coughlin JM; Du Y; Rosenthal HB; Slania S; Min Koo S; Park A; Solomon G; Vranesic M; Antonsdottir I; Speck CL; Rootes-Murdy K; Lerner A; Rowe SP; Wang Y; Lesniak WG; Minn I; Bakker A; Smith GS; Dannals RF; Kuwabara H; Horti A; Wong DF; Pomper MG
    Neuroimage; 2018 Jan; 165():118-124. PubMed ID: 28993233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual-biomarker imaging of regional cerebral amyloid load and neuronal activity in dementia with PET and 11C-labeled Pittsburgh compound B.
    Meyer PT; Hellwig S; Amtage F; Rottenburger C; Sahm U; Reuland P; Weber WA; Hüll M
    J Nucl Med; 2011 Mar; 52(3):393-400. PubMed ID: 21321269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of novel PET probes, [18F]BCPP-EF, [18F]BCPP-BF, and [11C]BCPP-EM for mitochondrial complex 1 imaging in the living brain.
    Harada N; Nishiyama S; Kanazawa M; Tsukada H
    J Labelled Comp Radiopharm; 2013 Sep; 56(11):553-61. PubMed ID: 24285187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations in α4β2 nicotinic receptors in cognitive decline in Alzheimer's aetiopathology.
    Okada H; Ouchi Y; Ogawa M; Futatsubashi M; Saito Y; Yoshikawa E; Terada T; Oboshi Y; Tsukada H; Ueki T; Watanabe M; Yamashita T; Magata Y
    Brain; 2013 Oct; 136(Pt 10):3004-17. PubMed ID: 23975517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PET Imaging of Mitochondrial Complex I with 18F-BCPP-EF in the Brains of MPTP-Treated Monkeys.
    Tsukada H; Kanazawa M; Ohba H; Nishiyama S; Harada N; Kakiuchi T
    J Nucl Med; 2016 Jun; 57(6):950-3. PubMed ID: 26912430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amyloid imaging with carbon 11-labeled Pittsburgh compound B for traumatic brain injury.
    Hong YT; Veenith T; Dewar D; Outtrim JG; Mani V; Williams C; Pimlott S; Hutchinson PJ; Tavares A; Canales R; Mathis CA; Klunk WE; Aigbirhio FI; Coles JP; Baron JC; Pickard JD; Fryer TD; Stewart W; Menon DK
    JAMA Neurol; 2014 Jan; 71(1):23-31. PubMed ID: 24217171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Striatal and Cortical β-Amyloidopathy and Cognition in Parkinson's Disease.
    Shah N; Frey KA; Müller ML; Petrou M; Kotagal V; Koeppe RA; Scott PJ; Albin RL; Bohnen NI
    Mov Disord; 2016 Jan; 31(1):111-7. PubMed ID: 26380951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization and first human investigation of FIBT, a novel fluorinated Aβ plaque neuroimaging PET radioligand.
    Yousefi BH; Manook A; Grimmer T; Arzberger T; von Reutern B; Henriksen G; Drzezga A; Förster S; Schwaiger M; Wester HJ
    ACS Chem Neurosci; 2015 Mar; 6(3):428-37. PubMed ID: 25482310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain PET Imaging of α7-nAChR with [18F]ASEM: Reproducibility, Occupancy, Receptor Density, and Changes in Schizophrenia.
    Wong DF; Kuwabara H; Horti AG; Roberts JM; Nandi A; Cascella N; Brasic J; Weerts EM; Kitzmiller K; Phan JA; Gapasin L; Sawa A; Valentine H; Wand G; Mishra C; George N; McDonald M; Lesniak W; Holt DP; Azad BB; Dannals RF; Kem W; Freedman R; Gjedde A
    Int J Neuropsychopharmacol; 2018 Jul; 21(7):656-667. PubMed ID: 29522184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.